These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
56 related items for PubMed ID: 1944190
1. [Clinical significance of immunotherapy for lung cancer--present and future]. Watanabe Y, Shimizu J, Oda M, Yoshida M, Watanabe S, Iwa T. Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1217-20. PubMed ID: 1944190 [Abstract] [Full Text] [Related]
2. [Surgery and adjuvant therapy of non-small cell lung cancer]. Watanabe Y, Yamada T, Ichihashi T, Hashizume Y, Iwa T. Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1534-46. PubMed ID: 3524465 [Abstract] [Full Text] [Related]
9. [Immunochemotherapy of resectable lung cancer--a preliminary study on a comparison of the control, levamisole, and OK-432]. Okayasu T, Kashimura Y, Matano J, Kawabata M, Takeoka T, Hashimoto M, Tanabe T. Gan To Kagaku Ryoho; 1982 Sep; 9(9):1646-52. PubMed ID: 6764120 [Abstract] [Full Text] [Related]
13. [Postoperative adjuvant therapy for 189 patients with completely resected non-small cell lung cancer of stage III(A)]. Li Q, Gao JM, Liang PY, Xie FY, Liu GZ. Ai Zheng; 2004 Nov; 23(11 Suppl):1463-6. PubMed ID: 15566658 [Abstract] [Full Text] [Related]
14. [A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer]. Fukushima M, Tsushima T, Ito H, Fukuda Y, Maruyama A, Fujita H, Yagihashi N, Tsuge T, Ishioka T, Kudo T, Kishibe S, Sato T, Machida S, Kogawa R, Takashima K, Koie H, Fujita K. Gan To Kagaku Ryoho; 1996 Feb; 23(3):303-9. PubMed ID: 8712823 [Abstract] [Full Text] [Related]
16. Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trial. Matthay RA, Mahler DA, Beck GJ, Loke J, Baue AE, Carter DC, Mitchell MS. Cancer Res; 1986 Nov; 46(11):5963-8. PubMed ID: 3530442 [Abstract] [Full Text] [Related]
19. Final report of a randomized controlled study with streptococcal preparation OK-432 as a supplementary immunopotentiator for laryngeal cancer. Kimura T, Suzuki K, Motai H, Miyamoto N, Tsuge I, Ito Y, Baba S. Acta Otolaryngol Suppl; 1996 Nov; 525():135-41. PubMed ID: 8908288 [Abstract] [Full Text] [Related]